GLUTAMATERGIC SIGNALING IN THE BRAIN'S WHITE MATTER

被引:68
|
作者
Bakiri, Y. [1 ]
Burzomato, V. [1 ]
Frugier, G. [1 ]
Hamilton, N. B. [1 ]
Karadottir, R. [2 ]
Attwell, D. [1 ]
机构
[1] UCL, Dept Physiol, London WC1E 6BT, England
[2] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England
基金
英国惠康基金;
关键词
glutamate; NMDA; oligodendrocyte; ischemia; cerebral palsy; multiple sclerosis; RECEPTOR-MEDIATED EXCITOTOXICITY; OLIGODENDROCYTE PRECURSOR CELLS; DOMAIN-CONTAINING PROTEIN; NMDA RECEPTOR; GLIAL-CELLS; AMPA RECEPTORS; ISCHEMIC-INJURY; INTRACELLULAR CALCIUM; NITRIC-OXIDE; NG2; ANTIGEN;
D O I
10.1016/j.neuroscience.2008.01.015
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Glutamatergic signaling has been exceptionally well characterized in the brain's gray matter, where it underlies fast information processing, learning and memory, and also generates the neuronal damage that occurs in pathological conditions such as stroke. The role of glutamatergic signaling in the white matter, an area until recently thought to be devoid of synapses, is less well understood. Here we review what is known, and highlight what is not known, of glutamatergic signaling in the white matter. We focus on how glutamate is released, the location and properties of the receptors it acts on, the interacting molecules that may regulate trafficking or signaling of the receptors, the possible functional roles of glutamate in the white matter, and its pathological effects including the possibility of treating white matter disorders with glutamate receptor blockers. (C) 2009 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:266 / 274
页数:9
相关论文
共 50 条
  • [41] The Duchenne brain: A matter of grey and white
    Doorenweerd, N.
    Straathof, C. S. M.
    Dumas, E. M.
    Niks, E. H.
    Schrans, D. G. M.
    Wokke, B. H. A.
    van den Bergen, J. C.
    Webb, A. G.
    van Buchem, M. A.
    Hendriksen, J. G. M.
    Verschuuren, J. J. G.
    Kan, H. E.
    NEUROMUSCULAR DISORDERS, 2013, 23 (9-10) : 752 - 752
  • [42] Bone morphogenetic protein signaling:a promising target for white matter protection in perinatal brain injury
    Jill Chang
    Robert W.Dettman
    Maria L.V.Dizon
    Neural Regeneration Research, 2018, 13 (07) : 1183 - 1184
  • [43] Bone morphogenetic protein signaling: a promising target for white matter protection in perinatal brain injury
    Chang, Jill
    Dettman, Robert W.
    Dizon, Maria L. V.
    NEURAL REGENERATION RESEARCH, 2018, 13 (07) : 1183 - 1184
  • [44] The development of brain white matter microstructure
    Lebel, Catherine
    Deoni, Sean
    NEUROIMAGE, 2018, 182 : 207 - 218
  • [45] Effect of deep brain stimulation on brain network and white matter integrity in Parkinson's disease
    Huang, Li-Chuan
    Chen, Li-Guo
    Wu, Ping-An
    Pang, Cheng-Yoong
    Lin, Shinn-Zong
    Tsai, Sheng-Tzung
    Chen, Shin-Yuan
    CNS NEUROSCIENCE & THERAPEUTICS, 2022, 28 (01) : 92 - 104
  • [46] White matter hyperintensities and normal-appearing white matter integrity in the aging brain
    Maniega, Susana Munoz
    Hernandez, Maria C. Valdes
    Clayden, Jonathan D.
    Royle, Natalie A.
    Murray, Catherine
    Morris, Zoe
    Aribisala, Benjamin S.
    Gow, Alan J.
    Starr, John M.
    Bastin, Mark E.
    Deary, Ian J.
    Wardlaw, Joanna M.
    NEUROBIOLOGY OF AGING, 2015, 36 (02) : 909 - 918
  • [47] Reducing the effects of white matter lesions on measures of brain grey and white matter volumes
    Chard, D.
    Jackson, J.
    Miller, D.
    Wheeler-Kingshott, C.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S207 - S207
  • [48] Seeding-Competent Tau in Gray Matter Versus White Matter of Alzheimer's Disease Brain
    Wu, Ruozhen
    Gu, Jianlan
    Zhou, Dingwei
    Tung, Yunn Chyn
    Jin, Nana
    Chu, Dandan
    Hu, Wen
    Wegiel, Jerzy
    Gong, Cheng-Xin
    Iqbal, Khalid
    Liu, Fei
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 79 (04) : 1647 - 1659
  • [49] Effects of cholinesterase inhibition on brain white matter volume in Alzheimer's disease
    Venneri, Annalena
    Lane, Roger
    NEUROREPORT, 2009, 20 (03) : 285 - 288
  • [50] EFFECTS OF CHEMOTHERAPY IN PEDIATRIC PATIENTS ON THE BRAIN'S GREY AND WHITE MATTER STRUCTURE
    Cahaney, Christine
    Stefancin, Patricia
    Parker, Robert
    Preston, Thomas
    Meyer, Rina
    Gianillo, Cara
    Duong, Timothy
    Hogan, Laura
    PEDIATRIC BLOOD & CANCER, 2019, 66